IRIS
MESSINA, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.873
EU - Europa 13.012
AS - Asia 7.109
SA - Sud America 3.090
Continente sconosciuto - Info sul continente non disponibili 631
AF - Africa 235
OC - Oceania 19
AN - Antartide 1
Totale 37.970
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.400
RU - Federazione Russa 6.623
SG - Singapore 2.918
BR - Brasile 2.649
CN - Cina 2.008
IE - Irlanda 1.676
SE - Svezia 999
IT - Italia 962
HK - Hong Kong 733
DE - Germania 534
VN - Vietnam 497
PL - Polonia 479
FR - Francia 460
FI - Finlandia 365
UA - Ucraina 354
GB - Regno Unito 277
IN - India 210
CA - Canada 178
AR - Argentina 158
BD - Bangladesh 113
MX - Messico 104
IQ - Iraq 80
TR - Turchia 79
EC - Ecuador 76
ID - Indonesia 66
ZA - Sudafrica 65
NL - Olanda 56
AT - Austria 51
VE - Venezuela 51
CO - Colombia 47
MA - Marocco 45
UZ - Uzbekistan 45
PK - Pakistan 44
CR - Costa Rica 42
BE - Belgio 41
JP - Giappone 38
IL - Israele 37
ES - Italia 33
PY - Paraguay 32
CL - Cile 27
KE - Kenya 26
JM - Giamaica 25
CI - Costa d'Avorio 24
PE - Perù 22
TN - Tunisia 22
PH - Filippine 20
JO - Giordania 19
HN - Honduras 18
KZ - Kazakistan 18
NP - Nepal 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
UY - Uruguay 17
AZ - Azerbaigian 16
CZ - Repubblica Ceca 16
NI - Nicaragua 16
SV - El Salvador 16
EG - Egitto 15
LT - Lituania 13
PA - Panama 13
TT - Trinidad e Tobago 13
IR - Iran 12
OM - Oman 12
DO - Repubblica Dominicana 11
EU - Europa 11
GT - Guatemala 11
PT - Portogallo 11
NZ - Nuova Zelanda 10
PR - Porto Rico 10
PS - Palestinian Territory 10
SC - Seychelles 10
AU - Australia 9
DZ - Algeria 9
LB - Libano 9
AL - Albania 8
BO - Bolivia 8
KW - Kuwait 7
RO - Romania 7
RS - Serbia 7
AO - Angola 6
CW - ???statistics.table.value.countryCode.CW??? 6
EE - Estonia 5
HU - Ungheria 5
KR - Corea 5
LK - Sri Lanka 5
QA - Qatar 5
BS - Bahamas 4
CY - Cipro 4
GP - Guadalupe 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
Totale 37.306
Salva come PNG Salva come JPEG
Città #
Moscow 2.091
Ashburn 1.974
Dublin 1.668
Singapore 1.499
Dallas 1.147
Chandler 1.055
Jacksonville 804
San Jose 787
Beijing 734
Hong Kong 733
Council Bluffs 578
Nyköping 568
Warsaw 461
The Dalles 403
Princeton 367
Medford 307
Lauterbourg 283
Cambridge 263
Los Angeles 260
Des Moines 219
Ann Arbor 210
Messina 189
Dearborn 182
São Paulo 176
Ho Chi Minh City 160
Boardman 157
Buffalo 154
Munich 126
New York 115
Santa Clara 95
Lancaster 94
San Mateo 94
Hanoi 92
Rome 90
Tianjin 89
Redondo Beach 88
Rio de Janeiro 78
Shenyang 75
Wilmington 75
Jinan 71
Pune 70
Bremen 67
Turku 64
Guangzhou 62
Houston 60
Belo Horizonte 57
Atlanta 56
Frankfurt am Main 56
Brasília 55
Nanjing 54
Orem 50
Brooklyn 47
Phoenix 47
Porto Alegre 47
Curitiba 46
Woodbridge 46
Tashkent 43
Milan 40
Baghdad 39
Brussels 38
Dong Ket 38
North Bergen 38
Nuremberg 37
Hangzhou 36
Montreal 36
Chennai 35
Tokyo 35
Campinas 34
Zhengzhou 33
Guarulhos 32
Hebei 32
Ningbo 32
Seattle 32
Shanghai 32
Chicago 31
Toronto 31
San José 30
Vienna 28
Johannesburg 27
San Francisco 27
Denver 26
Ribeirão Preto 26
Guayaquil 25
Helsinki 25
Jakarta 25
Quito 25
Abidjan 24
Amsterdam 23
Haikou 23
Mexico City 23
London 22
Taizhou 22
Lappeenranta 21
Stockholm 21
Washington 21
Changsha 20
Nairobi 20
Nanchang 20
Salvador 20
Sorocaba 20
Totale 20.763
Salva come PNG Salva come JPEG
Nome #
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 270
24-Holter ECG in type II and III SMA 253
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 252
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 245
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 240
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 229
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 222
Nusinersen versus sham control in later-onset spinal muscular atrophy 213
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 209
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 208
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 207
A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features 204
Alexithymia, burden and resilience in ALS’ caregivers 204
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 203
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 202
Effect of exercise on telomere length and telomere proteins expression in mdx mice 202
Hippo signaling pathway is altered in Duchenne muscular dystrophy 200
Autonomic nervous system involvement in spinal muscular atrophy. 197
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 193
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 193
An observational study of functional abilities in infants, children, and adults with type 1 SMA 192
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 191
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 190
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 189
ANT1 is reduced in sporadic inclusion body myositis. 188
Pilot study of flavocoxid in ambulant DMD patients. 182
Pilot study of serial casting in muscular dystrophy patients. 179
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 178
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 177
Pilot study of serial casting of ankles in muscular dystrophy patients. 176
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 176
Apoptosis and apoptosis-related proteins in thyroid myopathies 174
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 174
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 174
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 171
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 171
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 170
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 169
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 169
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 169
Age and baseline values predict 12 and 24-month functional changes in type 2 SMA 168
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. 167
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 167
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 166
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 166
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 164
A comprehensive molecular approach in COLA6 related myopathies based on genomic sequencing, transcriptional analysis and array CGH. 164
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 163
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 163
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 162
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 161
Pilot study of flavocoxid in ambulant DMD patients. 161
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 160
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 160
Pilot study of flavocoxid in ambulant DMD patients. 159
Genomic Variations Affecting Biological Effects of Statins 159
The 24-month PUL changes and steroids correlation. 159
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 159
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 159
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 159
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 158
Severe rhabdomyolysis in a patient with “Heat Stroke” 158
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 157
Clinical variability in spinal muscular atrophy type III 155
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 154
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 154
Conceptualizing the relations between metacognition and executive functions in Amyotrophic Lateral Sclerosis (ALS) patients’ caregivers. A preliminary study 153
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 153
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 153
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 153
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 152
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 152
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 152
Development of an academic disease registry for spinal muscular atrophy 151
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 148
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 147
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 147
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 144
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 144
Implication of SIRT1 and its downstream pathways in dystrophic process. 144
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 143
Histological effects of givinostat in boys with Duchenne muscular dystrophy 143
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 143
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 143
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 143
6 min walking test 12 month changes in DMD: Correlation with genotype. 142
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 142
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 141
The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. 140
Expression of the trascription factor NFkB in different muscular dystrophies 140
study of flavocoxid in ambulant DMD patients. 139
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 135
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 135
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 135
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies: Analysis of the UK diagnostic service 2001-2013. 132
Bone quality in Duchenne muscular dystrophy 132
Pilot study of flavocoxid in ambulant DMD patients. 130
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 129
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 128
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 128
Totale 16.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.430 0 0 0 0 97 14 125 71 51 116 211 745
2022/20234.386 391 318 161 309 379 382 29 236 1.999 21 122 39
2023/20241.108 84 200 73 100 112 214 46 31 16 43 28 161
2024/20255.731 98 76 102 350 246 151 161 1.365 1.509 327 431 915
2025/202616.199 694 1.196 1.308 1.300 1.184 3.515 1.894 1.877 1.907 708 335 281
2026/20273.694 353 963 824 1.425 129 0 0 0 0 0 0 0
Totale 37.970